NCT05119270

Brief Summary

The main goal of this study is to compare traditional cataract surgery with two new technologies: the femtosecond laser and the new Active Sentry handpiece. The femtosecond laser is used in several fields of ophthalmology and allows to automate multiple key steps of cataract surgery. The new generation of handpiece called Active Sentry has the particularity to detect the pressure inside the eye in real time and to adjust it to avoid large variations. Theses technologies would potentially increase the efficacy and safety of standard cataract surgery. This study therefore aims at evaluating the differences in cumulative dissipated energy and endothelial cell loss between femtosecond laser assisted cataract surgery with the new Active Sentry handpiece compared to standard phaco with new (Active Sentry) or older handpieces (OZil).

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 15, 2021

Completed
16 days until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

4.2 years

First QC Date

November 2, 2021

Last Update Submit

March 17, 2026

Conditions

Keywords

Corneal Endothelial Cell LossCenturion Vision SystemInfiniti Vision Systemcumulative dissipated energyPhacoemulsificationActive Sentry handpieceLaser TherapyOzil handpiece

Outcome Measures

Primary Outcomes (2)

  • Corneal endothelial cell loss (Specular microscopy)

    Change in corneal endothelial cells count after cataract surgery

    Baseline, 1 month, 3 months

  • Cumulative dissipated energy

    Amount of energy used during phacoemulsification

    Peroperatively

Secondary Outcomes (4)

  • Central corneal thickness

    Baseline, 1 month, 3 months

  • Postoperative residual astigmatism

    Baseline, 3 months

  • Binocular uncorrected visual acuities for distance (6 meters)

    Baseline, 1 day, 2 weeks, 1 month, 3 months

  • Patient reported visual disturbances

    Baseline, 3 months

Study Arms (3)

Femtosecond laser assisted cataract surgery with Active Sentry handpiece

EXPERIMENTAL

Participants suffering from cataract who are candidates for femtosecond laser assisted cataract surgery

Device: Femtosecond laser assisted cataract surgery with Active Sentry handpiece

Standard phacoemulsification with the Active Sentry handpiece

EXPERIMENTAL

Participants suffering from cataract who are candidates for standard phacoemulsification with the new Active Sentry handpiece

Procedure: Standard phacoemulsification with the Active Sentry handpiece

Standard phacoemulsification with the OZil handpiece

EXPERIMENTAL

Participants suffering from cataract who are candidates for standard phacoemulsification with the traditional OZil handpiece

Procedure: Standard phacoemulsification with the OZil handpiece

Interventions

The LenSx laser (Alcon Laboratories Inc., USA) automates key steps in the procedure including capsulorhexis, incision making and phaco. The Frequency Domain - Optical Coherence Tomography (FD-OCT) optical imaging system provides high-resolution, real-time visualization of ocular structures and their dimensions. The device sends the results to the interface which programs the laser and indicates the exact location, size and depth of the desired incisions. Diagnostic tests: 1. Corneal topography: OPD-Scan Corneal topography photography, taken by specular reflection (OPD-Scan) by measuring corneal curvature, thickness and topography 2. Pachymetry: precise measurement of the thickness of the cornea using a pachymeter 3. Specular microscopy : Qualitative and quantitative analysis of the corneal endothelium.

Femtosecond laser assisted cataract surgery with Active Sentry handpiece

Phacoemulsification is done by using the Active Sentry handpiece to allow for a better control of the intraocular pressure throughout the surgery. Diagnostic tests: 1. Corneal topography: OPD-Scan Corneal topography photography, taken by specular reflection (OPD-Scan) by measuring corneal curvature, thickness and topography 2. Pachymetry: precise measurement of the thickness of the cornea using a pachymeter 3. Specular microscopy : Qualitative and quantitative analysis of the corneal endothelium.

Standard phacoemulsification with the Active Sentry handpiece

Phacoemulsification is done by using the traditional OZil handpiece that allows rotational movement of the phaco tip. Diagnostic tests: 1. Corneal topography: OPD-Scan Corneal topography photography, taken by specular reflection (OPD-Scan) by measuring corneal curvature, thickness and topography 2. Pachymetry: precise measurement of the thickness of the cornea using a pachymeter 3. Specular microscopy : Qualitative and quantitative analysis of the corneal endothelium.

Standard phacoemulsification with the OZil handpiece

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient (over 18 years of age)
  • Patients undergoing uncomplicated cataract surgery with intraocular lens implantation
  • Ability to provide informed consent;
  • Ability to be followed for the entire duration of the study.

You may not qualify if:

  • Minor patient (under 18 years of age)
  • Unable to give informed consent
  • Unable to be followed for the duration of the study
  • Another surgery combined with cataract extraction
  • History of ocular surgery
  • Patient with concomitant ocular diseases other than cataract (such as corneal, retinal, or glaucoma diseases)
  • Irregular corneal astigmatism or keratoconus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier de l'Université de Montréal

Montreal, Quebec, H2X 3E4, Canada

Location

Related Publications (13)

  • Kelman CD. Phaco-emulsification and aspiration. A new technique of cataract removal. A preliminary report. Am J Ophthalmol. 1967 Jul;64(1):23-35. No abstract available.

    PMID: 6028631BACKGROUND
  • Nagy Z, Takacs A, Filkorn T, Sarayba M. Initial clinical evaluation of an intraocular femtosecond laser in cataract surgery. J Refract Surg. 2009 Dec;25(12):1053-60. doi: 10.3928/1081597X-20091117-04.

    PMID: 20000286BACKGROUND
  • Bille JF, editor. High Resolution Imaging in Microscopy and Ophthalmology: New Frontiers in Biomedical Optics [Internet]. Cham (CH): Springer; 2019. No abstract available. Available from http://www.ncbi.nlm.nih.gov/books/NBK554051/

    PMID: 32091677BACKGROUND
  • Liu Y, Zeng M, Liu X, Luo L, Yuan Z, Xia Y, Zeng Y. Torsional mode versus conventional ultrasound mode phacoemulsification: randomized comparative clinical study. J Cataract Refract Surg. 2007 Feb;33(2):287-92. doi: 10.1016/j.jcrs.2006.10.044.

    PMID: 17276271BACKGROUND
  • Solomon KD, Lorente R, Fanney D, Cionni RJ. Clinical study using a new phacoemulsification system with surgical intraocular pressure control. J Cataract Refract Surg. 2016 Apr;42(4):542-9. doi: 10.1016/j.jcrs.2016.01.037.

    PMID: 27113876BACKGROUND
  • Al-Mohtaseb Z, He X, Yesilirmak N, Waren D, Donaldson KE. Comparison of Corneal Endothelial Cell Loss Between Two Femtosecond Laser Platforms and Standard Phacoemulsification. J Refract Surg. 2017 Oct 1;33(10):708-712. doi: 10.3928/1081597X-20170731-01.

    PMID: 28991340BACKGROUND
  • Chen X, Xiao W, Ye S, Chen W, Liu Y. Efficacy and safety of femtosecond laser-assisted cataract surgery versus conventional phacoemulsification for cataract: a meta-analysis of randomized controlled trials. Sci Rep. 2015 Aug 13;5:13123. doi: 10.1038/srep13123.

    PMID: 26269445BACKGROUND
  • Ye Z, Li Z, He S. A Meta-Analysis Comparing Postoperative Complications and Outcomes of Femtosecond Laser-Assisted Cataract Surgery versus Conventional Phacoemulsification for Cataract. J Ophthalmol. 2017;2017:3849152. doi: 10.1155/2017/3849152. Epub 2017 Apr 30.

    PMID: 28540082BACKGROUND
  • Saeedi OJ, Chang LY, Ong SR, Karim SA, Abraham DS, Rosenthal GL, Hammer A, Spagnolo BV, Betancourt AE. Comparison of cumulative dispersed energy (CDE) in femtosecond laser-assisted cataract surgery (FLACS) and conventional phacoemulsification. Int Ophthalmol. 2019 Aug;39(8):1761-1766. doi: 10.1007/s10792-018-0996-x. Epub 2018 Jul 27.

    PMID: 30054849BACKGROUND
  • Bascaran L, Alberdi T, Martinez-Soroa I, Sarasqueta C, Mendicute J. Differences in energy and corneal endothelium between femtosecond laser-assisted and conventional cataract surgeries: prospective, intraindividual, randomized controlled trial. Int J Ophthalmol. 2018 Aug 18;11(8):1308-1316. doi: 10.18240/ijo.2018.08.10. eCollection 2018.

    PMID: 30140634BACKGROUND
  • Krarup T, Holm LM, la Cour M, Kjaerbo H. Endothelial cell loss and refractive predictability in femtosecond laser-assisted cataract surgery compared with conventional cataract surgery. Acta Ophthalmol. 2014 Nov;92(7):617-22. doi: 10.1111/aos.12406. Epub 2014 Jun 2.

    PMID: 24888390BACKGROUND
  • Jiraskova N, Stepanov A. OUR EXPERIENCE WITH ACTIVE SENTRY AND CENTURION OZIL HANDPIECES. Cesk Slov Oftalmol. 2021 Winter;77(1):18-21. doi: 10.31348/2021/1.

    PMID: 33740863BACKGROUND
  • Ho JW, Afshari NA. Advances in cataract surgery: preserving the corneal endothelium. Curr Opin Ophthalmol. 2015 Jan;26(1):22-7. doi: 10.1097/ICU.0000000000000121.

    PMID: 25415300BACKGROUND

MeSH Terms

Conditions

Corneal Endothelial Cell LossCataractAstigmatism

Condition Hierarchy (Ancestors)

Corneal DiseasesEye DiseasesEye ManifestationsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsLens DiseasesRefractive Errors

Study Officials

  • Georges Durr, MD, FRCSC

    Centre hospitalier de l'Université de Montréal (CHUM)

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: 3 groups will be compared: * Group 1: 30 participants suffering from cataract who are candidates for femtosecond laser assisted cataract surgery * Group 2: 30 participants suffering from cataract who are candidates for traditional cataract surgery with the Active Sentry handpiece * Group 3: 30 participants suffering from cataract who are candidates for traditional cataract surgery with the OZil handpiece
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 2, 2021

First Posted

November 15, 2021

Study Start

December 1, 2021

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

March 19, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations